, there may have been a selection bias
with stent placement in both the SMA and CA reserved
for patients with a suboptimal results of SMA treatment
alone. Revascularization of both the CA and SMA may
have a role in select patients with severe gastric ischemia
and those without adequate collaterals. However, there
is no proven beneÔ¨Åt that revascularizing both vessels provides more durable relief, and the second (or additional)
intervention adds cost and potential